Page 4
Evolve BioSystems revolves to series D
UC Davis's probiotics spinout secured an undisclosed amount as Bow Capital backed the first close of a series D round with a $55m target.
Daily deal net: February 9, 2021
Today's deal net contains news from Nexthink, Metalenz, Grapheal, CellulaRevolution and Astrata.
Vivino pours $155m into series D
PreSeed Ventures-backed Vivino runs a wine recommendation platform and has raised $155m in a series D round after adding 21 million users in three years.
Soci cements $80m series D
Retail brand management business Soci has assembled $115m to date from investors including Stanford University's Daper Fund.
Vect-Horus collects $14.5m
The Institute for Neurophysiopathology spinout has completed a series D round.
J-Pharma jacks series D up to $21m
Fidelity provided a $4.8m second tranche after a first close featuring vehicles for Kyushu University and Osaka University.
Investors hook up Hinge Health with $300m
IP Group portfolio company Hinge Health has pushed its valuation to $3bn following a $300m series D round co-led by Coatue Management and Tiger Global.
Gojo finds series D mojo
Tokyo University of Science helped extend Gojo & Company's series D round to $68.6m, lifting the microfinancing provider's overall funding to around $142m.
Investors endow Endomag with $20m
Existing backers including Draper Esprit and Sussex Place Ventures have reinvested to bring Endomag’s overall funding to above $43m.
Recursion takes $239m funding excursion
University of Utah's drug discovery technology producer has raised series D funding to increase its post-money valuation to some $1.2bn.